Peter Turvey

Peter Turvey spent over 28 years being involved in the biotechnology industry, most of which were as general counsel and company secretary in Australia’s largest biotechnology company CSL Limited. Mr Turvey was heavily involved in CSL’s acquisitions and divestments, and was directly responsible for the protection and licensing of its intellectual property.

Lists and Charts

Share Transactions

Related Information

Positions - Previous

Position	Company	Year
Non-Executive Director	Starpharma Holdings	2012 - 2021
Non-Executive Director	Viralytics	2014 - 2018
Non-Executive Director	Admedus	2012 - 2016
Non-Executive Director	Admedus	2012 - 2016
Non-Executive Director	Anteris Technologies	- 2016
Group General Counsel, Company Secretary	CSL	1998 - 2009

Directors Interest

Company	Date	Transaction type	Number of shares	Price per share	Transaction value	Nature of change
Starpharma Holdings	2020-11-04	Bought	13,334	$1.50	$20,000	Other
Admedus	2016-02-05	Other	274,255	$0.00		Other
Admedus	2016-02-05	Other	274,255	$0.00		Other
Admedus	2015-12-10	Issued	19,036	$0.81	$15,400	Other
Admedus	2015-12-10	Other	317,204	$0.00		Other

Explore Full List